Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: PROSTATIC NEOPLASMS - THERAPY , . Treffer: 5
2018
Renner, W; Krenn-Pilko, S; Gruber, HJ; Herrmann, M; Langsenlehner, T
Relative telomere length and prostate cancer mortality.
Prostate Cancer Prostatic Dis. 2018; 21(4):579-583
Doi: 10.1038/s41391-018-0068-3
Web of Science
PubMed
FullText
FullText_MUG
2017
Renner, W; Langsenlehner, U; Krenn-Pilko, S; Eder, P; Langsenlehner, T
BCL2 genotypes and prostate cancer survival.
Strahlenther Onkol. 2017; 193(6):466-471
Doi: 10.1007/s00066-017-1126-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Smolle, MA; Bauernhofer, T; Pummer, K; Calin, GA; Pichler, M
Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Int J Mol Sci. 2017; 18(2):
Doi: 10.3390/ijms18020473
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Rauchenwald, M; Bauernhofer, T; De Santis, M; Füreder, T; Höltl, W; Kramer, G; Krause, S; Loidl, W; Oismüller, R; Reissigl, A; Schmeller, N; Stackl, W; Stoiber, F; Krainer, M
Treatment of castration refractory Prostate cancer.
Wien Klin Wochenschr. 2012; 124(15-16):538-551
Doi: 10.1007/s00508-012-0206-1
Web of Science
PubMed
FullText
FullText_MUG
Seiler, D; Randazzo, M; Leupold, U; Zeh, N; Isbarn, H; Chun, FK; Ahyai, SA; Baumgartner, M; Huber, A; Recker, F; Kwiatkowski, M
Protocol-based active surveillance for low-risk prostate cancer: anxiety levels in both men and their partners.
Urology. 2012; 80(3):564-9
Doi: 10.1016/j.urology.2012.04.053
Web of Science
PubMed
FullText
FullText_MUG